Survival Strategies for the Global In Vitro Diagnostics Industry

Slowing US and European Markets Demand Alignment with Global Market Needs

Regular Price: USD 1,500

Special Price USD 1,350

10% OFF

* Required Fields

Regular Price: USD 1,500

Special Price USD 1,350

PAY BY INVOICE

Be the first to review this product

While there is a positive outlook for global in vitro diagnostics (IVD), top companies face challenges such as slowing growth, increasing competition, and a changing business environment. This market insight will analyze the current healthcare reality and effective strategies in 2014 and beyond. The study will examine high-growth IVD segments and the global competitive landscape. It will include a determination of the regions in which opportunities exist through 2020 and beyond. Global healthcare expenditures in key countries and regions will be presented. The market insight also will review external technology partners.

Table of Contents

Survival Strategies for the Global In Vitro Diagnostics IndustryAnalysis of Underpenetrated Markets and Other OpportunitiesNew IVD Strategies




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 08-Dec-17

Region : Global

Release Date : 08-Dec-17

Region : Global

Release Date : 08-Dec-17

Region : Global

Release Date : 08-Dec-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.